Ghinwa Dumyati, MD, FSHEA Associate Professor of Medicine, University of Rochester Medical Center Director for the Communicable Diseases and Surveillance program, Center for Community Health Rochester, New York, USA Dr. Ghinwa Dumyati is board certified in infectious disease and is an active member of the Infectious Disease Society of North America (IDSA) and a Fellow of the Society for Healthcare Epidemiology of America (SHEA). In her current role she is responsible for leading research initiatives focused on surveillance for emerging and healthcare associated infections (HAI) and prevention of HAI in the local Rochester area. Her most notable undertakings are leading two collaborative quality improvement projects in Rochester hospitals with a focus on reducing the burden of HAI. Her initial collaboration focused on reducing central line associated bloodstream infections (CLABSI) outside the intensive care units and achieved a 56% reduction in CLABSI incidence across six Rochester area hospitals. Her current project focuses on prevention of C. difficile infections (CDI) in four Rochester hospitals through enhanced infection prevention and environmental cleaning. Dr. Dumyati also serves on the Advisory Committee of the IPRO Quality Improvement Organization for Preventing HAI in New York State and she is Co-Chair of the Statewide Infection Prevention Workgroup for the New York State Partnership for Patients. _______________________________________________________________________________________________ Steven Gordon, MD Chairman, Department of Infectious Diseases Cleveland Clinic Foundation Cleveland, OH, USA Dr. Steven Gordon is the Chairman of the Department of Infectious Diseases at the Cleveland Clinic Foundation and President (2011) of the Society Healthcare Epidemiology of America (SHEA). He is Associate Professor of Medicine at the Lerner College of Medicine at Case Western University. He has an interest in prevention of nosocomial infections and has served on HICPAC (2003-7). His clinical interests include infective endocarditis including cardiac electronic implantable device infections as well as opportunistic infections in immunocompromised patients. He is a Fellow in the American College of Internal Medicine and a Member of the Infectious Disease Society of America. He attended Hamilton College and Cornell University Medical College with a subsequent internship and residency in internal medicine at the University of Chicago Hospital and Clinics. He was an Epidemic Intelligence Officer in the Hospital Infections Program at the Centers for Disease Control and did a fellowship in infectious diseases at Emory University School of Medicine. Dr. Gordon has received a number of honors and awards over the years. Most recently, he was the Sherwood B. Winslow, M.D., Distinguished Lecturer for the Healthcare Leadership Forum. He has also presented a number of national and international meetings, as well as having published more than 100 articles and multiple book chapters. He enjoys tennis and jogging with his dog (Lola) and spending time with his wife, Anne, and three beautiful daughters.
_______________________________________________________________________________________________ Lynn Hadaway, MEd, RN-BC, CRNI President Lynn Hadaway Associates, Inc. Milner, Georgia, USA Lynn Hadaway currently serves as president of Lynn Hadaway Associates, Inc, a consulting and education company specializing in infusion therapy and vascular access. Her company designs, develops and delivers infusion therapy education through Internet based technologies and in traditional classroom settings. She provides consulting services to device manufacturers on issues of product design, clinical applications for products, review of literature and other published evidence, and education and training. She is an active member of the Infusion Nurses Society, currently serving as the Chair of the INS Infusion Team Task Force and has served on the Standards of Practice committee since 2004. She is also a member of the Association for Vascular Access, the Association for Practitioners in Infection Control, and the Georgia Nurses Association. She holds two national certifications -- infusion nursing from the Infusion Nurses Certification Corporation and nursing professional development from the American Nurses Credentialing Corporation. She also holds a Masters in Education from the University of Georgia. Lynn has more than 40 years of experience in infusion nursing and adult education. Her experience comes from multiple acute care settings, healthcare manufacturing, and continuing professional education. Her publications include many aspects of vascular access devices, anatomy and physiology, nursing care of all types of vascular access devices, infusion and vascular access complication management, legal and regulatory issues, and principles of adult learning.
_______________________________________________________________________________________________
John Jernigan, MD, MS Director – Office of HAI Prevention Research and Evaluation Center for Disease Control Atlanta, Georgia, USA John Jernigan is currently the director of the Office of HAI Prevention Research and Evaluation of the Centers for Disease Control and Prevention (CDC)’s Division of Healthcare Quality Promotion (DHQP). He is also a Clinical Associate Professor of Medicine at the Emory University School of Medicine in the Division of Infectious Diseases. Jernigan attended medical school at Vanderbilt University, where he also completed his internship and residency in Internal Medicine, and served as Chief Medical Resident. Following his residency, he spent a year practicing medicine in East Africa. He later returned to the United States to complete his fellowship in Infectious Diseases at the University of Virginia, where he also earned a Masters Degree in Epidemiology. He joined the faculty of Emory University in 1994, and became Hospital Epidemiologist at Emory University Hospital in 1995. In Spring, 2000, he joined the Division of Healthcare Quality Promotion at the CDC, but maintains his faculty appointment in the Emory Division of Infectious Diseases. He has served on the Board of Directors for both the Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA). He was named the SHEA Investigator awardee in 2005. His editorial activities have included service on the Editorial Board of Infection Control and Hospital Epidemiology and Hospital Epidemiology Section Editor for Current Infectious Disease Reports. He has authored/coauthored numerous peer-reviewed publications and textbook chapters dealing with the epidemiology of healthcare-associated infections and antimicrobial resistance, and has a particular interest in the epidemiology of drug-resistant Staphylococcus aureus. _______________________________________________________________________________________________
David Knoke, PhD Professor of Sociology University of Minnesota Minneapolis, Minnesota, USA
David Knoke is professor of sociology at the University of Minnesota, where he teaches courses in statistics, networks, and organizations. He received his Ph.D. in 1972 from the University of Michigan and was professor of sociology at Indiana University from 1972 to 1985. He was a Fulbright research scholar at Kiel University (1989) and a fellow at the Center for Advanced Study in the Behavioral Sciences (1992). In 2008, he received the University of Minnesota College of Liberal Arts’ Arthur “Red” Motley Exemplary Teaching Award. With various colleagues, he received several National Science Foundation research grant and published the results in research monographs on political, organizational, and social network behavior. Some of these books are The Organizational State, Organizing for Collective Action, Political Networks, Organizations in America, Comparing Policy Networks, Changing Organizations, Social Network Analysis, and Economic Networks. His current research investigates diverse social networks, including intra- and interorganizational, health care, economic, financial, terrorist and counterterror networks.
_______________________________________________________________________________________________
Mervyn Mer, MD Principal Specialist Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand Johannesburg, South Africa
Professor Mer currently presides as a principal specialist at the Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa. Professor Mer’s academic background includes a MBBCh degree from the University of the Witwatersrand, as well as a Dip PEC (South Africa), FCP (South Africa), MMed (University of the Witwatersrand) and a PhD. He has a pulmonology subspecialty as well as Cert Critical Care (SA). He is a fellow of the Royal College of Physicians (London, UK) and of the College of Chest Physicians (United States). Professor Mer is involved in various aspects of clinical research, is a hands-on clinician and has participated in more than 800 lectures and presentations. He is extensively involved in postgraduate and undergraduate teaching and serves as an examiner for the Colleges of Medicine of South Africa in several disciplines. In addition, Professor Mer has published numerous journal articles, at regional and international level, has been a contributor to book chapters, consensus documents, various national guidelines and is the author of the booklet, Antifungal Pocket Guide for Systemic Fungal Infections. His PhD work related to central venous catheter-related infection, and he is about to publish a new book on the understanding and practical use of antimicrobials based on an original and unique template. He has been an invited reviewer for several peer review journals. Professor Mer is currently the President of the Critical Care Society of Southern Africa (CCSSA), until recently ran the portfolio of Continuing Medical Education for the South African Thoracic Society (SATS) for more than a decade, and is a foundermember and current vice-President of the Southern African Society of Thrombosis and Haemostasis (SASTH). He has received numerous awards including the Surgeon General Commendation Award, the Phillip V. Tobias and Convocation Clinical Award for Distinguished Teaching (highest teaching award offered by the Faculty of Health Sciences, University of the Witwatersrand), The FJ Milne Department of Medicine Service and Teaching Award (premier award conferred to a member of the Department of Medicine, University of the Witwatersrand), the President’s Award of the Critical Care Society of Southern Africa (highest award offered by the CCSSA to a doctor for outstanding contributions to Critical Care) and the Sam Naidoo Award for the best clinician, conferred by the Southern African Society of Thrombosis and Haemostasis. Most recently, he was the first recipient of the Hilda Datnow Jacobson award (awarded to the most competent, caring and capable doctor in the profession, irrespective of field of interest).
_______________________________________________________________________________________________ Rafael Santana Mondragón, MD, MSc Adjunct General Director for Coordination of the General Health Council Mexico City, Mexico Dr. Rafael Santana Mondragón is a surgeon currently serving as the Adjunct General Director for Coordination of the General Health Council in Mexico. His specialty is Internal Medicine at Central Military Hospital with a Master’s Degree in Science and specialty in Immunology, National School of Biological Sciences National Pediatric Institute. He received certification as a specialist in clinical immunology and allergy by the respective council. Dr. Mondragón is Professor of Immunology at Military Medical School. Adjunct Professor of Clinical Immunology in the Department of immunology of National School of Biological Sciences of the National Pediatric Institute (NPI), an annex to the Laboratory of Microbiology and Immunology of Military Medical School. From 1974 until 1985 he served in a variety of roles at the NPI including: Participating Physician in the Immunology Service, Professor of General Immunology, and UNAM Faculty of Chemistry. In addition, Dr. Mondragón was a Member of the Pedagogical Council, Military Medical School, Research Fellow, Bone and Joint Research Unit, University of London, London Hospital (White Chapel) (1981-82) and Research Associate “C” in National Pediatrics Institute and Head of the Immunohematology Service of Military Central Hospital. In 1984 he served as Coordinator of Immunodeficiency Referral Centers of the Coordination of National Health Institutes of the Secretariat of Health and Assistance in Mexico. Between 1992 and 1994 he served as Head of the Technical Division and National Coordinator of Education and Research of the Directorate General of Health. In 199597 he was Operative Sub director of Health (SEDENA), followed by being Director of Military Central Hospital. In 2006 he was Head of the Department of Academic Committees of the Division of Post-Graduate Studies, Subdivision of Medical Specialties of the UNAM Faculty of Medicine. In the last 6 years Dr. Mondragón has played a key role in Mexican Social Service as the Evaluation Coordinator in the Secretariat of Clinical Education. Dr. Mondragón, as Professor of Immunology, has lectured in of over 177 courses on immunology, internal medicine and medical education and authored and co-authored over 36 articles in national and international magazines. _______________________________________________________________________________________________ Regina Nailon, RN, PhD Clinical Nurse Researcher, Nursing Research and Quality Outcomes The Nebraska Medical Center Omaha, Nebraska, USA
Dr. Nailon provides strategic vision and direction for the advancement of nursing research and meaningful use of data in clinical decision making at The Nebraska Medical Center. In addition to facilitating and conducting interdisciplinary health services research aimed at improving not only health outcomes but the healthcare infrastructure necessary for the delivery of safe and appropriate care across the care continuum, Dr. Nailon mentors colleagues and provides guidance as they incorporate evidence-based practices into clinical settings to impact patient outcomes in a positive manner. Dr. Nailon has a strong background in community health with an emphasis on program evaluation and outcomes measurement, and over 15 years of research, evidence-based practice, and quality improvement experience. She earned a PhD from Oregon Health & Science University and completed a postdoctoral fellowship at the Center for Health Outcomes and Policy Research at the University of Pennsylvania in Philadelphia.
_______________________________________________________________________________________________ Russell Nassof, Esq Executive Vice President RiskNomics Scottsdale, Arizona, USA Mr. Nassof has been involved in the field of environmental and health risk consulting for over 25 years, concentrating his work in the areas of industrial hygiene, microbial contamination, toxic tort risk management, insurance defense, and infection control. Many of his risk management programs have been adopted as underwriting standards by the insurance industry and are used as risk barometers to evaluate emerging environmental and health related issues. In the area of infection control, Mr. Nassof developed a unique multi-faceted infection control program designed to reduce infection rates and provide legally defensible documentation to the healthcare provider as well as the insurance industry. He has also been involved as a consulting/testifying expert in the field of emerging toxic torts including mold, nanotechnology, bedbugs, Norovirus, and legionella. Mr. Nassof began his career as an attorney in New York in the insurance industry and later became president of Environomics, a national environmental consulting and expert firm with offices throughout the United States. He sold Environomics in 2004 to TRC, a NYSE international consulting corporation and took a position with TRC as the Director of Strategic Environmental Initiatives. He recently left TRC and re-established his own firm, RiskNomics, which provides healthcare and environmental consulting services on HAI risk related issues. Mr. Nassof has presented hundreds of seminars to legal, insurance, loss control, healthcare, and risk management groups throughout the United States, Canada, Europe, and Australia. He has coauthored books on microbial contamination, published numerous articles and holds a patent on a microbial sensing device currently under development in Canada. His risk management involvement has included managing high profile events such as the flooding at more than 7 New Orleans hospitals following Hurricane Katrina and the Monte Carlo Las Vegas hotel fire. Mr. Nassof received his Juris Doctorate and undergraduate degrees from Emory University in Atlanta. _______________________________________________________________________________________________ Victor Rosenthal, MD, MSc, CIC Founder & Chairman International Nosocomial Infection Control Consortium (INICC) Buenos Aires, Argentina Dr. Rosenthal graduated from the University of Buenos Aires where he completed fellowship programs in Internal Medicine and Infectious Disease. He earned a certificate in Infection Control (CIC) and Hospital Epidemiology from the Chilean Society of Infection Control and is a graduate in Clinical Effectiveness from Harvard University and the University of Buenos Aires. He was an Infectious Diseases fellow at the University of Wisconsin and has completed infection control courses offered by APIC, SHEA, and JCAHO. He is chairman of an Infection Control and Hospital Epidemiology course at the Medical College of Buenos Aires and a visiting professor at the University of Wisconsin. In 1998, Dr. Rosenthal founded the International Nosocomial Infection Control Consortium (INICC), a nonprofit international research center which focuses on HealthcareAssociated Infections networking with more than 1500 researchers in more than 47 countries. Dr. Rosenthal has been a task force member and reviewer of the Infection Control Guidelines for the World Health Organization (WHO) since 2005, and a member of the Technical Advisory Panel and coauthor of the Guidelines to Prevent Central Line Associated Bloodstream Infections of the Joint Commission International and Joint Commission
continued for Health Care Accreditation since 2009. Since 1993 he has advised the governments of Argentina, Colombia, Mexico, Taiwan, and Hong Kong, and has collaborated with numerous countries to develop Infection Control Guidelines. Dr. Rosenthal is an author of more than 350 scientific publications, including peer reviewed manuscripts and book chapters, and an editorial board member and scientific reviewer of more than 70 international peer reviewed journals such as Lancet, Critical Care Medicine, American Journal of Infection Control (AJIC), and Infection Control and Hospital Epidemiology (ICHE). He has received several awards granted at different international scientific meetings, including APIC, IFIC, Pan American Meetings, Mexican, Chilean, and others.
________________________________________________________________________ Jack Stoltzfus, PhD, LP Founder Executive Leadership Consultants Shoreview, MN, USA Dr. Stoltzfus is a consultant, coach and trainer with Executive Leadership Consultants, a company he founded in 2011. He provides the following services: Executive Assessment; Executive Coaching; Leadership Training Design and Implementation, Direct Training Services in Coaching and Leadership; Training Program Delivery; Team Building; Program Evaluation; and, Consultation on Engagement and Retention. In March of 2011 Dr. Stoltzfus took an early retirement from 3M Company after 26 years in management. In the 12 years prior to his leaving, he had been a manager within 3M’s Talent Solutions Department. His specific focus was working with 3M’s Executives and High Potential Leaders through classroom, action learning, assessment and individual coaching. He has coached a number of senior executives at 3M on ways to improve their leadership effectiveness, engagement and business results. In the last ten years, Dr. Stoltzfus has successfully worked with leaders both within and outside of 3M using a coaching model for leaders that delivers improvement in leadership effectiveness, engagement of team members, and business results. Jack has a master’s degree from the University of St. Thomas and a PhD from the University of Wisconsin, both in Counseling Psychology. He is a licensed psychologist in the State of Minnesota. _______________________________________________________________________________________________
Moderator Patrick Parks, MD, PhD Medical Director, Critical & Chronic Care Solutions Division 3M Company St. Paul, MN, USA Dr. Parks received both his MD and PhD degrees from Case Western Reserve University in Cleveland, Ohio (USA). He was in clinical practice for 10 years at a University-affiliated hospital prior to joining 3M. He has been with 3M for more than 20 years and is currently the Medical Director of the 3M Critical & Chronic Care Solutions Division. In addition to his 3M position, he is an Adjunct Associate Professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota. His current interests and responsibilities include research and technologies related to catheter related bloodstream infections and wound healing.
